Dan Pettitt

1.7k total citations
15 papers, 1.3k citations indexed

About

Dan Pettitt is a scholar working on Pharmacology, Surgery and Rheumatology. According to data from OpenAlex, Dan Pettitt has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 4 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in Dan Pettitt's work include Inflammatory mediators and NSAID effects (6 papers), Drug-Induced Adverse Reactions (4 papers) and Lipoproteins and Cardiovascular Health (2 papers). Dan Pettitt is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Drug-Induced Adverse Reactions (4 papers) and Lipoproteins and Cardiovascular Health (2 papers). Dan Pettitt collaborates with scholars based in United States, United Kingdom and Canada. Dan Pettitt's co-authors include Mason W. Russell, Gurkirpal Singh, Jeffrey D. Miller, Frederick Wolfe, Gerardo Heiss, Brad C. Astor, Josef Coresh, Mark J. Sarnak, Deeb N. Salem and Daniel E. Weiner and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Society of Nephrology and American Heart Journal.

In The Last Decade

Dan Pettitt

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Pettitt United States 13 427 270 242 230 212 15 1.3k
Alessandro Pierucci Italy 22 621 1.5× 167 0.6× 393 1.6× 50 0.2× 431 2.0× 65 1.7k
Gonzalo Calvo Spain 21 236 0.6× 189 0.7× 617 2.5× 142 0.6× 41 0.2× 45 1.6k
D. H. Lawson United Kingdom 22 221 0.5× 121 0.4× 140 0.6× 112 0.5× 177 0.8× 52 1.5k
Elisabeth Ejerblad Sweden 10 93 0.2× 80 0.3× 160 0.7× 202 0.9× 377 1.8× 23 1.1k
Michel Andréjak France 22 219 0.5× 85 0.3× 426 1.8× 54 0.2× 201 0.9× 115 1.6k
Gerald Levy United States 11 476 1.1× 204 0.8× 257 1.1× 36 0.2× 166 0.8× 17 1.1k
David M. Clive United States 9 422 1.0× 136 0.5× 78 0.3× 30 0.1× 302 1.4× 15 1.1k
Mette Charlot Denmark 20 281 0.7× 246 0.9× 986 4.1× 70 0.3× 31 0.1× 39 2.1k
Patrick Sheridan Canada 12 177 0.4× 275 1.0× 282 1.2× 76 0.3× 45 0.2× 13 1.8k
Jean‐Claude Aldigier France 23 90 0.2× 73 0.3× 625 2.6× 163 0.7× 622 2.9× 63 1.9k

Countries citing papers authored by Dan Pettitt

Since Specialization
Citations

This map shows the geographic impact of Dan Pettitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Pettitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Pettitt more than expected).

Fields of papers citing papers by Dan Pettitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Pettitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Pettitt. The network helps show where Dan Pettitt may publish in the future.

Co-authorship network of co-authors of Dan Pettitt

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Pettitt. A scholar is included among the top collaborators of Dan Pettitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Pettitt. Dan Pettitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pettitt, Dan, et al.. (2016). Novel intraoperative applications for the metal suction cannula. Annals of The Royal College of Surgeons of England. 98(5). 344–345. 2 indexed citations
2.
DiBonaventura, Marco, Shaloo Gupta, Margaret V. McDonald, et al.. (2012). Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey. Health and Quality of Life Outcomes. 10(1). 30–30. 65 indexed citations
3.
Tang, Simon, et al.. (2009). Does Synchronizing Initiation of Therapy Affect Adherence to Concomitant Use of Antihypertensive and Lipid-Lowering Therapy?. American Journal of Therapeutics. 16(2). 119–126. 26 indexed citations
4.
Astor, Brad C., Josef Coresh, Gerardo Heiss, Dan Pettitt, & Mark J. Sarnak. (2006). Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. American Heart Journal. 151(2). 492–500. 159 indexed citations
5.
Tighiouart, Hocine, Daniel E. Weiner, John L. Griffith, et al.. (2005). Anemia as a Risk Factor for Cardiovascular Disease and All-Cause Mortality in Diabetes. Journal of the American Society of Nephrology. 16(11). 3403–3410. 237 indexed citations
6.
Morant, S. V., et al.. (2004). Application of a propensity score to adjust for channelling bias with NSAIDs. Pharmacoepidemiology and Drug Safety. 13(6). 345–353. 12 indexed citations
7.
Selby, Joe V., Tiffany Peng, Andrew J. Karter, et al.. (2004). High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population.. PubMed. 10(2 Pt 2). 163–70. 77 indexed citations
8.
Wolfe, Frederick, Sean Z. Zhao, & Dan Pettitt. (2004). Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.. PubMed. 31(6). 1143–51. 42 indexed citations
9.
Schinnar, Rita, Andrea J. Apter, David J. Margolis, et al.. (2004). Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. American Journal of Ophthalmology. 138(1). 178–178. 6 indexed citations
10.
Strom, Brian L., Rita Schinnar, Andrea J. Apter, et al.. (2003). Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics. New England Journal of Medicine. 349(17). 1628–1635. 219 indexed citations
11.
Singh, Gurkirpal, Jeffrey D. Miller, Daniel M. Huse, et al.. (2003). Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.. PubMed. 30(4). 714–9. 67 indexed citations
12.
Rahme, Elham, Dan Pettitt, & Jacques LeLorier. (2002). Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis & Rheumatism. 46(11). 3046–3054. 72 indexed citations
13.
Wolfe, Frederick, Nancy C. Flowers, Thomas Burke, Lester Arguelles, & Dan Pettitt. (2002). Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis.. PubMed. 29(5). 1015–22. 54 indexed citations
14.
Wolfe, Frederick, et al.. (2002). Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.. PubMed. 29(3). 467–73. 53 indexed citations
15.
Singh, Gurkirpal, et al.. (2002). Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey.. PubMed. 8(15 Suppl). S383–91. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026